Picture of Athenex logo

ATNXQ — Athenex News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Athenex Inc expected to post a loss of 15  cents a share - Earnings Preview

* Athenex Inc  ATNX.OQ   ATNX.O  is expected to show a rise
in
quarterly revenue when it reports  results on July 28. 
    * The Buffalo New York-based  company is expected to report 
a
42.6% increase in revenue to $31.262 million from $21.92 million
a year ago, according to the mean estimate from 3 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Athenex Inc is for
a loss
of 15 cents per share. For the same quarter last year, the
company reported a loss of 33 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Athenex Inc
is
$3​, above​ its last closing price of $0.62. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2022  -0.19       -0.19      -0.16     Beat    15.8
 Dec. 31 2022              -0.18      -0.32     Missed  -81.1
 Sep. 30 2021  -0.36       -0.37      -0.33     Beat    10.4​
 Jun. 30 2021  -0.41       -0.37      -0.33     Beat    10
 ​​Mar.        -0.41       -0.40      -0.27     Beat    33.2
 31 2021                                                
 Dec. 31 2020  -0.42       -0.44      -0.53     Missed  -20.9​
 Sep. 30 2020  -0.43       -0.43      -0.44     Missed  -3
 Jun. 30 2020  -0.37       -0.36      -0.50     Missed  -39.5
 This summary was machine generated July 26 at 18:35 GMT.  All
figures in US dollars  unless otherwise stated

Recent news on Athenex

See all news